Shirvani H, Ghanavi J, Aliabadi A, Mousavinasab F, Talebi M, Majidpoor J, et al. MiR-211 plays a dual role in cancer development: from tumor suppressor to tumor enhancer. Cell Signal. 2023;101:110504.

Article  CAS  PubMed  Google Scholar 

Khasraghi LB, Nouri M, Vazirzadeh M, Hashemipour N, Talebi M, Zarch FA, et al. MicroRNA-206 in human cancer: mechanistic and clinical perspectives. Cell Signal. 2023;101:110525.

Article  Google Scholar 

Zarch SMA, Tezerjani MD, Talebi M, Mehrjardi MYV. Molecular biomarkers in diabetes mellitus (DM). Med J Islam Repub Iran. 2020;34:28.

Google Scholar 

Aghaei M, Khodadadian A, Elham K-N, Nazari M, Babakhanzadeh E. Major miRNA involved in insulin secretion and production in beta-cells. Int J Gen Med. 2020;13:89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dehghani M, Zarch SMA, Mehrjardi MYV, Nazari M, Babakhanzadeh E, Ghadimi H, et al. Evaluation of miR-181b and miR-126-5p expression levels in T2DM patients compared to healthy individuals: relationship with NF-κB gene expression. Endocrinol Diabetes Nutr. 2020;67(7):454–60.

Article  Google Scholar 

Aghaei Zarch SM, Vahidi Mehrjardi MY, Babakhanzadeh E, Nazari M, Talebi M, Zeniali F, et al. MiR-181b expression levels as molecular biomarker for type 2 diabetes. J Mazandaran Univ Med Sci. 2019;29(176):195–201.

Google Scholar 

Babakhanzadeh E, Khodadadian A, Nazari M, Tezerjani MD, Aghaei SM, Ghasemifar S, et al. Deficient expression of DGCR8 in human testis is related to spermatogenesis dysfunction, especially in meiosis I. Int J Gen Med. 2020;13:185.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci. 2006;103(7):2257–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jopling C. Liver-specific microRNA-122: Biogenesis and function. RNA Biol. 2012;9(2):137–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kunden RD, Khan JQ, Ghezelbash S, Wilson JA. The role of the liver-specific microRNA, miRNA-122 in the HCV replication cycle. Int J Mol Sci. 2020;21(16):5677.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lewis AP, Jopling CL. Regulation and biological function of the liver-specific miR-122. Biochem Soc Trans. 2010;38(6):1553–7.

Article  CAS  PubMed  Google Scholar 

Zeinali F, Aghaei Zarch SM, Jahan-Mihan A, Kalantar SM, Vahidi Mehrjardi MY, Fallahzadeh H, et al. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: a case control study. PLoS ONE. 2021;16(6):e0251697.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lowey B, Hertz L, Chiu S, Valdez K, Li Q, Liang TJ. Hepatitis C virus infection induces hepatic expression of NF-κB-inducing kinase and lipogenesis by downregulating miR-122. MBio. 2019;10(4):e01617-e1619.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Long J-K, Dai W, Zheng Y-W, Zhao S-P. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Mol Med. 2019;25(1):1–13.

Article  CAS  Google Scholar 

Zhang Z, Li H, Chen S, Li Y, Cui Z, Ma J. MicroRNA-122 regulates caspase-8 and promotes the apoptosis of mouse cardiomyocytes. Braz J Med Biol Res. 2017;50:e5760.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shah V, Shah J. Recent trends in targeting miRNAs for cancer therapy. J Pharm Pharmacol. 2020;72(12):1732–49.

Article  CAS  PubMed  Google Scholar 

Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1(1):1–9.

Google Scholar 

Barajas JM, Reyes R, Guerrero MJ, Jacob ST, Motiwala T, Ghoshal K. The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer. Sci Rep. 2018;8(1):1–10.

Article  CAS  Google Scholar 

Li X-N, Yang H, Yang T. miR-122 inhibits hepatocarcinoma cell progression by targeting LMNB2. Oncol Res. 2020;28(1):41.

Article  PubMed  PubMed Central  Google Scholar 

Okuyama S, Marusawa H, Matsumoto T, Ueda Y, Matsumoto Y, Endo Y, et al. Excessive activity of apolipoprotein B mRNA editing enzyme catalytic polypeptide 2 (APOBEC2) contributes to liver and lung tumorigenesis. Int J Cancer. 2012;130(6):1294–301.

Article  CAS  PubMed  Google Scholar 

Li A, Wu J, Zhai A, Qian J, Wang X, Qaria MA, et al. HBV triggers APOBEC2 expression through miR-122 regulation and affects the proliferation of liver cancer cells. Int J Oncol. 2019;55(5):1137–48.

CAS  PubMed  Google Scholar 

Cheng D, Deng J, Zhang B, He X, Meng Z, Li G, et al. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. EBioMedicine. 2018;36:159–70.

Article  PubMed  PubMed Central  Google Scholar 

Lee HM, Wong WKK, Fan B, Lau ES, Hou Y, Luk AOY, et al. Detection of increased serum miR-122-5p and miR-455-3p levels before the clinical diagnosis of liver cancer in people with type 2 diabetes. Sci Rep. 2021;11(1):1–11.

Google Scholar 

Meng L, Chen Z, Jiang Z, Huang T, Hu J, Luo P, et al. MiR-122-5p suppresses the proliferation, migration, and invasion of gastric cancer cells by targeting LYN. Acta Biochim Biophys Sin. 2020;52(1):49–57.

Article  CAS  PubMed  Google Scholar 

Xu X, Gao F, Wang J, Tao L, Ye J, Ding L, et al. MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4. Cancer Biol Ther. 2018;19(5):427–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rao M, Zhu Y, Zhou Y, Cong X, Feng L. MicroRNA-122 inhibits proliferation and invasion in gastric cancer by targeting CREB1. Am J Cancer Res. 2017;7(2):323.

CAS  PubMed  PubMed Central  Google Scholar 

Pei Z, Zhang Z, Hu A, Yang F, Gai Y. miR-122-5p inhibits tumor cell proliferation and induces apoptosis by targeting MYC in gastric cancer cells. Die Pharmazie-Int J Pharm Sci. 2017;72(6):344–7.

CAS  Google Scholar 

Maruyama S, Furuya S, Shiraishi K, Shimizu H, Saito R, Akaike H, et al. Inhibition of apoptosis by miR-122-5p in α-fetoprotein-producing gastric cancer. Oncol Rep. 2019;41(4):2595–600.

CAS  PubMed  Google Scholar 

Xu Z, Liu G, Zhang M, Zhang Z, Jia Y, Peng L, et al. miR-122-5p inhibits the proliferation, invasion and growth of bile duct carcinoma cells by targeting ALDOA. Cell Physiol Biochem. 2018;48(6):2596–606.

Article  CAS  PubMed  Google Scholar 

Kong L, Wu Q, Zhao L, Ye J, Li N, Yang H. Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway. Cell Cycle. 2019;18(11):1212–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu H, Mi Y, Jiang X, Zhou X, Li R, Wei Z, et al. Hepatocyte nuclear factor 6 inhibits the growth and metastasis of cholangiocarcinoma cells by regulating miR-122. J Cancer Res Clin Oncol. 2016;142(5):969–80.

Article  CAS  PubMed  Google Scholar 

Yin W, Xu J, Li C, Dai X, Wu T, Wen J. Circular RNA circ_0007142 facilitates colorectal cancer progression by modulating CDC25A expression via miR-122-5p. Onco Targets Ther. 2020;13:3689.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun L, Liu X, Pan B, Hu X, Zhu Y, Su Y, et al. Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis. J Cancer. 2020;11(3):630.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, Zhang X, Jin Z, Yin T, Duan C, Sun J, et al. MiR-122 promotes the development of colon cancer by targeting ALDOA in vitro. Technol Cancer Res Treat. 2019;18:1533033819871300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Yu P-Y, Yu J-P, Luo J-D, Sun Z-Q, Sun F, et al. KIF22 promotes progress of esophageal squamous cell carcinoma cells and is negatively regulated by miR-122. Am J Transl Res. 2021;13(5):4152.

CAS  PubMed  PubMed Central  Google Scholar 

Zhang H-S, Zhang F-J, Li H, Liu Y, Du G-Y, Huang Y-H. Tanshinone IIA inhibits human esophageal cancer cell growth through miR-122-mediated PKM2 down-regulation. Arch Biochem Biophys. 2016;598:50–6.

Article  CAS  PubMed  Google Scholar 

Lu W, Zhang Y, Zhou L, Wang X, Mu J, Jiang L, et al. miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma. Tumor Biol. 2016;37(12):15615–25.

Article  CAS  Google Scholar 

Liu Y, Liu J, Wang Z, Zhu X, Chen X, Wang M. MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci. 2019;23(2):622–9.